2008 Key Figures

Performance over five years


Consolidated sales (€ million)
Year 2004 2005 2006 2007 2008
Key 13 641 14 533 15 790 17 063 17 542

Operating Profit (€ million)
Year 2004 2005 2006 2007 2008
Result 2 089 2 266 2 541 2 827 2 725

Pre-tax profit excluding non recurrent items* (€ million)
Year 2004** 2005 2006 2007 2008
Result 2 187 2 370 2 638 2 896 2 788

Net profit excluding non recurrent items after minority interests* (€ million)
Year 2004** 2005 2006 2007 2008
Result 1 486 1 639 1 833 2 039 2 064

* Non-recurrent items include capital gains and losses on long-term asset disposals, depreciation of long-term assets and restructuring costs. See note 10 of the Notes to the Consolidated Financial Statements in Volume 2 of the 2008 Annual Report (pages 25 and 26).

** For comparison purpose, 2004 pro forma profit and loss accounts are restated in order to reflect the deconsolidation of Sanofi-Synthélabo at January 1st, 2004:
  – by replacing the share in net income of Sanofi-Synthélabo, €293.5 million, by the received dividends, €145.9 million,
  - and by neutralizing the net of tax dilution capital gain relating to these shares, €2,854.5 million before any deduction and €471.1 million of taxes.

View the key figures chapter
Print key figures